These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 15198545)

  • 1. Identification of chemically modified peptide from poly(D,L-lactide-co-glycolide) microspheres under in vitro release conditions.
    Murty SB; Goodman J; Thanoo BC; DeLuca PP
    AAPS PharmSciTech; 2003 Oct; 4(4):E50. PubMed ID: 15198545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
    Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impurity formation studies with peptide-loaded polymeric microspheres Part I. In vivo evaluation.
    Murty SB; Thanoo BC; Wei Q; DeLuca PP
    Int J Pharm; 2005 Jun; 297(1-2):50-61. PubMed ID: 15893894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation.
    Murty SB; Na DH; Thanoo BC; DeLuca PP
    Int J Pharm; 2005 Jun; 297(1-2):62-72. PubMed ID: 15885939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
    Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
    Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylation of octreotide: I. Separation of positional isomers and stability against acylation by poly(D,L-lactide-co-glycolide).
    Na DH; DeLuca PP
    Pharm Res; 2005 May; 22(5):736-42. PubMed ID: 15906168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Octreotide Acylation Inside PLGA Microspheres by Derivatization of the Amines of the Peptide with a Self-Immolative Protecting Group.
    Shirangi M; Najafi M; Rijkers DT; Kok RJ; Hennink WE; van Nostrum CF
    Bioconjug Chem; 2016 Mar; 27(3):576-85. PubMed ID: 26726953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of exenatide in poly(D,L-lactide-co-glycolide) solutions: a simplified investigation on the peptide degradation by the polymer.
    Liang R; Zhang R; Li X; Wang A; Chen D; Sun K; Liu W; Li Y
    Eur J Pharm Sci; 2013 Nov; 50(3-4):502-10. PubMed ID: 23994054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and in vitro evaluation of 1- and 4-month controlled release orntide PLA and PLGA microspheres.
    Kostanski JW; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2000; 5(4):585-96. PubMed ID: 11109259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
    Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
    J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
    Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
    J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of uniform poly(d,l-lactide) and poly(d,l-lactide-co-glycolide) microspheres using a microfluidic chip for comparison.
    Yang CH; Huang KS; Grumezescu AM; Wang CY; Tzeng SC; Chen SY; Lin YH; Lin YS
    Electrophoresis; 2014 Feb; 35(2-3):316-22. PubMed ID: 23857679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
    Wang J; Wang BM; Schwendeman SP
    J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.
    Shirangi M; Hennink WE; Somsen GW; van Nostrum CF
    Pharm Res; 2015 Sep; 32(9):3044-54. PubMed ID: 25832500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
    Janoria KG; Mitra AK
    Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
    Tomoda K; Makino K
    Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
    Kim JH; Taluja A; Knutson K; Han Bae Y
    J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation.
    Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX
    Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.